Hangzhou Bio-Sincerity Pharma-Tech Drops 9.03%, IPO in 2021 Peaked with 1.2 Billion Yuan Overfunding

Deep News11-05

Hangzhou Bio-Sincerity Pharma-Tech Co., Ltd. (301096.SZ) closed at 55.99 yuan today, down 9.03%. The stock is currently trading below its IPO price.

The company listed on the Shenzhen Stock Exchange's ChiNext board on December 20, 2021, issuing 27.0417 million shares at 79.60 yuan per share. The lead underwriter was Guojin Securities, with Yu Bo and Geng Xudong as sponsors. On its debut, the stock hit a record high of 120 yuan.

Hangzhou Bio-Sincerity Pharma-Tech raised a total of 2.153 billion yuan in its IPO, with net proceeds of 1.863 billion yuan after deducting issuance costs. The final net proceeds exceeded the original target by 1.213 billion yuan.

According to the prospectus disclosed on December 15, 2021, the company initially planned to raise 651 million yuan, entirely allocated for its headquarters and R&D center project in Hangzhou. Total issuance expenses amounted to 289 million yuan, including 262 million yuan in underwriting and sponsorship fees.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1156837411?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-05 17:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1156837411","market":"fut","top_or_hot":-1,"title":"Hangzhou Bio-Sincerity Pharma-Tech Drops 9.03%, IPO in 2021 Peaked with 1.2 Billion Yuan Overfunding","media":"Deep News","content":"<p>Hangzhou Bio-Sincerity Pharma-Tech Co., Ltd. (301096.SZ) closed at 55.99 yuan today, down 9.03%. The stock is currently trading below its IPO price.</p>\n<p>The company listed on the Shenzhen Stock Exchange's ChiNext board on December 20, 2021, issuing 27.0417 million shares at 79.60 yuan per share. The lead underwriter was Guojin Securities, with Yu Bo and Geng Xudong as sponsors. On its debut, the stock hit a record high of 120 yuan.</p>\n<p>Hangzhou Bio-Sincerity Pharma-Tech raised a total of 2.153 billion yuan in its IPO, with net proceeds of 1.863 billion yuan after deducting issuance costs. The final net proceeds exceeded the original target by 1.213 billion yuan.</p>\n<p>According to the prospectus disclosed on December 15, 2021, the company initially planned to raise 651 million yuan, entirely allocated for its headquarters and R&D center project in Hangzhou. Total issuance expenses amounted to 289 million yuan, including 262 million yuan in underwriting and sponsorship fees.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hangzhou Bio-Sincerity Pharma-Tech Drops 9.03%, IPO in 2021 Peaked with 1.2 Billion Yuan Overfunding</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHangzhou Bio-Sincerity Pharma-Tech Drops 9.03%, IPO in 2021 Peaked with 1.2 Billion Yuan Overfunding\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1039043262\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Deep News </p>\n<p class=\"h-time\">2025-11-05 17:20</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hangzhou Bio-Sincerity Pharma-Tech Co., Ltd. (301096.SZ) closed at 55.99 yuan today, down 9.03%. The stock is currently trading below its IPO price.</p>\n<p>The company listed on the Shenzhen Stock Exchange's ChiNext board on December 20, 2021, issuing 27.0417 million shares at 79.60 yuan per share. The lead underwriter was Guojin Securities, with Yu Bo and Geng Xudong as sponsors. On its debut, the stock hit a record high of 120 yuan.</p>\n<p>Hangzhou Bio-Sincerity Pharma-Tech raised a total of 2.153 billion yuan in its IPO, with net proceeds of 1.863 billion yuan after deducting issuance costs. The final net proceeds exceeded the original target by 1.213 billion yuan.</p>\n<p>According to the prospectus disclosed on December 15, 2021, the company initially planned to raise 651 million yuan, entirely allocated for its headquarters and R&D center project in Hangzhou. Total issuance expenses amounted to 289 million yuan, including 262 million yuan in underwriting and sponsorship fees.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0216","symbol_name":"研究试验","start_time":0,"source_url":"","article_id":"1156837411","we_media_id":"1039043262","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1156837411","pubTimestamp":1762334445,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Deep News","introduction":"Global Stock Market Deep Analysis","home_visible":1,"id":"1039043262","head_image":"https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922"},"summary":"Hangzhou Bio-Sincerity Pharma-Tech Co., Ltd. (301096.SZ) closed at 55.99 yuan today, down 9.03%. The stock is currently trading below its IPO price. The company listed on the Shenzhen Stock...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"301096":"百诚医药","BK0216":"研究试验"},"translate_title":"杭州生诚医药跌9.03%2021年IPO见顶超募12亿元","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"301096":1},"content_text":"Hangzhou Bio-Sincerity Pharma-Tech Co., Ltd. (301096.SZ) closed at 55.99 yuan today, down 9.03%. The stock is currently trading below its IPO price.\nThe company listed on the Shenzhen Stock Exchange's ChiNext board on December 20, 2021, issuing 27.0417 million shares at 79.60 yuan per share. The lead underwriter was Guojin Securities, with Yu Bo and Geng Xudong as sponsors. On its debut, the stock hit a record high of 120 yuan.\nHangzhou Bio-Sincerity Pharma-Tech raised a total of 2.153 billion yuan in its IPO, with net proceeds of 1.863 billion yuan after deducting issuance costs. The final net proceeds exceeded the original target by 1.213 billion yuan.\nAccording to the prospectus disclosed on December 15, 2021, the company initially planned to raise 651 million yuan, entirely allocated for its headquarters and R&D center project in Hangzhou. Total issuance expenses amounted to 289 million yuan, including 262 million yuan in underwriting and sponsorship fees.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1156837411","isCrawlerRequest":true}